Arie Mayer Oramed Pharmaceuticals Inc. (ORMP) insider trading activity

Arie Mayer is Director of ORAMED PHARMACEUTICALS INC.. Currently has a direct ownership of 133,109 shares of ORMP, which is worth approximately $279,528. The most recent transaction as insider was on Jun 05, 2025, when has been sold 36,975 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 133K

38.46% 3M change

38.46% 12M change

Total Value Held $279,528

Arie Mayer Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 05 2025	BUY Grant, award, or other acquisition	-	36,975 Added 21.74%	133,109 Common Stock
Jan 04 2024	BUY Grant, award, or other acquisition	-	39,325 Added 29.03%	96,134 Common Stock
Apr 17 2023	BUY Grant, award, or other acquisition	-	30,000 Added 34.56%	56,809 Common Stock
Apr 04 2023	BUY Open market or private purchase	$8,398 $2.21 p/Share	3,800 Added 12.41%	26,809 Common Stock
Apr 03 2023	BUY Open market or private purchase	$11,119 $2.22 p/Share	5,009 Added 17.88%	23,009 Common Stock
Jul 28 2022	BUY Grant, award, or other acquisition	-	12,000 Added 40.0%	18,000 Common Stock
Jan 03 2022	BUY Grant, award, or other acquisition	-	6,000 Added 40.0%	9,000 Common Stock
Nov 01 2021	SELL Open market or private sale	$76,800 $25.6 p/Share	3,000 Reduced 100.0%	0 Common Stock

Arie Mayer

Director

Kfar Saba, L3

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ORMP shares.

Notify only if

Value

Insider Trading

Get notified when an Oramed Pharmaceuticals Inc. insider buys or sells ORMP shares.

Notify only if

Operation

Value

Type

News

Receive news related to ORAMED PHARMACEUTICALS INC.

Track Activities on ORMP

Account